TL;DR
- Idea: Decentralized post-quantum security mesh (dPoSec-based) that turns every connected device into an incentivized validator node, providing real-time quantum-resistant trust for Web2 & Web3.
- Catalyst: Token Generation Event and multi-exchange listings on July 31 2025; growing enterprise partnerships and $120 k bug-bounty highlight momentum.
- Risks: Extreme launch-phase volatility, unproven mainnet, reliance on adoption by external blockchains and enterprises, and competitive landscape in L2 security and DePIN.
- Score: 8.00/ 10
Coin
- Name/ Ticker: Naoris Protocol (NAORIS)
- Segment: Post-Quantum DePIN/ Cyber-secur
- Status: active
- Price: $0.046580
Key Metrics
- Market Cap: $27 914 023
- FDV: $186 320 000
- Circulating Supply: 599 260 000
- Total Supply: 4 000 000 000
- Inflation: 0.00%
Sources
Technology
- USP: First production-ready post-quantum DePIN security layer (Sub-Zero) with dPoSec consensus and Swarm AI.
- Core Technology: dPoSec (Decentralized Proof-of-Security) consensus + NIST-aligned PQC (Dilithium/KEM) + decentralized Swarm AI mesh.
Roadmap
- 2025-01-31: Public DePIN Testnet launch
- 2025-07-31: $NAORIS Token Generation Event & CEX listings
- 2025-09-15: Browser security node v2 release
- 2025-10-30: Mobile security node SDK
- 2025-12-15: Mainnet launch (Sub-Zero Layer)
- 2026-02-28: Governance DAO activation
Team & Investors
Team
- Founder & CEO β David Carvalho: 20+ yrs ethical-hacker, ex-nation-state cyber advisor
- Co-Founder & COO β Monica Oravcova: 15 yrs IT/cybersecurity for Fortune 100
- CTO β Sumit Chauhan: 20 yrs enterprise blockchain & AI
- Chief Marketing Officer β Guy Davies: 20 yrs tech marketing, 7 yrs crypto
- Chief Strategy Officer β David Holtzman: Former CTO Network Solutions, ex-IBM scientist
Investors
- Draper Associates β Undisclosed β’ 2022-07-27
- Mason Labs β Strategic β’ 2025-05-29 β’ $3.00M
- Level One Robotics β Strategic β’ 2025-05-29
- Tradecraft Capital β Strategic β’ 2025-05-29
- Expert Dojo β Undisclosed β’ 2022-07-27
- Holt Xchange β Undisclosed β’ 2022-07-27
- Uniera β Undisclosed β’ 2022-07-27
- Frekaz Group β Strategic β’ 2025-05-29
- Holdun Family Office β Undisclosed β’ 2022-07-27
- Brendan Holt Dunn β Undisclosed β’ 2022-07-27
Total funding: $14.50M
Tokenomics
- Utility: Staking for validator/security nodes, payment for security services & PQ audits, governance voting.
- Vesting: Team & advisor tokens (16.23%) vest monthly over 36 months after 6-month cliff; investor tokens (14.99%) vest quarterly over 24 months; community & strategic reserve unlocked linearly over 48 months.
Pros & Cons
Strengths
- Strong post-quantum tech moat
- Experienced cyber-security leadership
- Backed by reputable VCs (Draper, Mason Labs)
- Low initial market cap (<$30 m)
- Clear enterprise use-cases across Web2 & Web3
- dPoSec offers measurable real-time trust metrics
- Active testnet with >100 m PQ transactions
- Multi-chain compatible Sub-Zero Layer
- Token utility tightly linked to network security
Weaknesses
- No mainnet yet; tech unproven at scale
- High token supply (4 bn) may dilute
- Extreme launch-phase price volatility
- Heavy reliance on enterprise adoption
- Regulatory uncertainty around security tokens
- Competitive landscape with other L2 security projects
- Limited current liquidity across major CEXs
- Complex tech may hinder developer onboarding
- Token unlock schedules could pressure price
Market Signals (7d)
- TVL trend: no_data
- CEX volume trend: spiking
- Active addresses trend: spiking
Price Scenarios (target: 2026-02-01)
How to Buy & Store
CEX
- Binance Alpha
- Gate.io
- MEXC
- Bitget
- Phemex
- ZBX
DEX
- Uniswap
- SushiSwap
- 1inch
- Balancer
- KyberSwap
Storage
- MetaMask
- Trust Wallet
- Ledger Nano
- Trezor Model T
- SafePal
- Rabby
- imToken
Verdict
Naoris Protocol offers differentiated post-quantum security tech with early adoption traction and respected investors. While execution and market volatility remain key risks, the sub-$30 m market cap provides an attractive asymmetric opportunity for risk-tolerant investors.
Official Links
Source: Coin Research (internal)
Comments (0)